GL1X · GenesisL1 explorer

MolNFT v2 · #128970 · protein

Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP)

5NUM: “Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP)”. X-ray diffraction at 2.3, 2 ligands (Z80, PO4). MolNFT v2 #128970 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5NUM
Type
protein
Length
158 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.3
Source
Bos taurus
UniProt
P02754
Ligands
Z80, PO4

Structure

x-ray diffraction · resolution 2.3 · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein158—P02754

Ligands and binding sites

  • Z80 · 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine · ligand · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5NUM · Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine… · the same entry in another collection · chain A against A, TM-score 1.00
  • P02754 · AlphaFold monomer V2.0 prediction for beta-lactoglobulin (P02754) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.